Unknown

Dataset Information

0

PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.


ABSTRACT: This study was aimed to determine the role and regulation of progranulin (PGRN) in the pathogenesis of inflammatory bowel diseases (IBD). Dextran sulfate sodium (DSS)-, picrylsulfonic acid (TNBS)-induced, bone marrow chimera and CD4+CD45Rb(hi) T cell transfer colitis model were established and analyzed in wild-type and several genetically-modified mice, including PGRN, IL-10 and TNFR2 deficient mice. Elevated levels of PGRN were found in colitis samples from human IBD patients and mouse colitis models in comparison to the corresponding controls. PGRN-deficient mice became highly susceptible to DSS- and TNBS-induced colitis, whereas recombinant PGRN ameliorated the pathology and reduced the histological score in both DSS and TNBS colitis models. In addition, hematopoietic-derived PGRN was critical for protection against DSS-induced colitis, and lack of PGRN signaling in CD4+ T cells also exacerbated experimental colitis. PGRN-mediated protective effect in colitis was compromised in the absence of IL-10 signaling. In addition, PGRN's effect was also largely lost in the TNFR2-deficient colitis model. Collectively, these findings not only provide the new insight into PGRN's anti-inflammatory action in vivo, but may also present PGRN and its derivatives as novel biological agent for treating IBD.

SUBMITTER: Wei F 

PROVIDER: S-EPMC4228332 | biostudies-other | 2014 Nov

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC3582134 | biostudies-literature
| S-EPMC4700431 | biostudies-literature
| S-EPMC6082386 | biostudies-literature
| S-EPMC8588024 | biostudies-literature
| S-EPMC2757440 | biostudies-literature
| S-EPMC8227069 | biostudies-literature
| S-EPMC2763592 | biostudies-literature
| S-EPMC3331970 | biostudies-literature
| S-EPMC10694202 | biostudies-literature
| S-EPMC5216697 | biostudies-literature